share_log

'Corning Announces Collaboration With NIBRT To Help Accelerate Cell Therapy Development'

'Corning Announces Collaboration With NIBRT To Help Accelerate Cell Therapy Development'

'康寧宣佈與NIBRT合作,以加快電芯治療的研發'
Benzinga ·  06/18 22:48

Corning's cutting-edge Ascent Fixed Bed Bioreactor System will be integrated into the institute's renowned training and curriculum programs.

康寧公司的尖端Ascent Fixed Bed Bioreactor System 將被集成到該研究所著名的培訓和課程計劃中。

CORNING, N.Y. — Corning Incorporated (NYSE:GLW) today announced a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT), one of the world's premier centers for biopharmaceutical-manufacturing research and training. Under the agreement, NIBRT will host one of Corning's cutting-edge Ascent Fixed Bed Bioreactor (FBR) Systems at its Advanced Therapies building in Dublin, Ireland.

紐交所 - 康寧公司(NYSE:GLW)今天宣佈與國家生物加工研究和培訓中心(NIBRT)合作,NIBRT是全球最頂尖的生物製藥研究和培訓中心之一。根據協議,NIBRT將在其位於愛爾蘭都柏林的先進療法大廈中,接納康寧公司尖端的Ascent Fixed Bed Bioreactor(FBR)系統中的其中之一。

Corning's Ascent FBR System is an automated bioproduction platform that facilitates the efficient growth and harvesting of large quantities of viable cells, an ongoing challenge for biopharmaceutical manufacturers. It produces high yields of adherent cells, which are used in many areas of modern medicine, including cell therapy, gene therapy, cell-based immuno-oncology, and tissue engineering. The Ascent system has the potential to help shorten the path to clinical applications of cell and gene therapies.

康寧公司的Ascent FBR System是一種自動化生產平台,可促進大量存活細胞的有效生長和收穫,這是生物製藥製造商持續挑戰的問題。它可生產大量黏附細胞,這些細胞在當代醫學的許多領域中被使用,包括細胞療法、基因療法、細胞免疫顯效和組織工程學。Ascent系統有可能有助於縮短細胞和基因療法的臨床應用路徑。

NIBRT will integrate the Ascent system into its customized courses and trainings and provide demonstrations for NIBRT visitors. The collaboration further opens the door for Corning to the life sciences market in Europe, and to the fast-growing Irish market. Ireland is now the third largest exporter of pharmaceuticals in the world.

NIBRT將把Ascent系統整合到其定製課程和培訓中,併爲NIBRT的訪客提供演示。該合作進一步爲康寧公司走向歐洲生命科學市場和快速增長的愛爾蘭市場打開了大門。愛爾蘭現在是全球第三大藥品出口國。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論